Calamos Russell 2000 Structured Alt Protection ETF – April (CPRA)

CPRA targets investors seeking Russell 2000 exposure — the roughly 2,000 smallest public U.S. companies by market capitalization — with a hedge against annual losses. Like its Nasdaq-100 siblings, CPRA is structured around a collar (long puts, long calls, short calls) expiring 12 months from April 1 each year. But where the Nasdaq-100 funds track large-cap technology and consumer stocks, CPRA brings the volatility and risk profile of the small-cap segment, where valuations swing wider and company-specific risks loom larger.

The Russell 2000 and its volatility

The Russell 2000 Index consists of the smallest 2,000 companies in the Russell 3000 (itself the 3,000 largest U.S. companies by market cap). The typical Russell 2000 constituent is a profitable but unglamorous business — regional banks, industrial suppliers, specialty retailers, software shops, equipment manufacturers. These stocks are riskier than large caps: each company is smaller, less diversified, more exposed to regional economic cycles and competitive disruption.

Annual volatility in the Russell 2000 typically runs 18–25%, compared to 12–15% for the S&P 500. That higher volatility translates to wider price swings and, consequently, higher option premiums. When Calamos negotiates the collar for CPRA each April, it has more volatility to work with, which typically means a wider range between the cap and the floor — and thus a more attractive cap rate than comparable Nasdaq-100 or S&P 500 structured products might offer.

As of June 2026 (with roughly 10 months remaining in the April 2025–March 2026 outcome period), CPRA’s cap stood at 5.43% (gross) with a floor of -2.32%, leaving investors roughly 2.32 points of downside before full protection applied. At inception in April 2025, the cap would have been several percentage points higher.

The April reset calendar

CPRA’s annual cycle aligns to the calendar year’s second month, differentiating it from CPNQ (December) and CPNS (September). This choice is arbitrary — purely a matter of product design — but it does create an investor cohort effect. Someone buying CPRA in January has nearly a full year of outcome period ahead; someone buying in March has only weeks. Like all structured products, the benefit is tied to holding through the full outcome period, from April 1 of one year to March 31 of the next.

Small-cap-specific risks

The Russell 2000’s constituents are more sensitive to interest rates, recessions, and competitive disruption than large caps. If the Federal Reserve tightens sharply or the economy contracts, small caps often outpace large caps on the downside. CPRA’s 100% downside protection buffers against that scenario — but only if held through the outcome period. An investor who buys in February, expects a spring market bounce, and sells in June during a summer correction would miss the protection entirely.

Additionally, liquidity in Russell 2000 stocks is more fragile than in mega-cap names. During market stress, bid-ask spreads widen and execution costs rise. The fund’s underlying positions are FLEX options on the iShares Russell 2000 ETF (IWM), so the fund is exposed to IWM’s tracking fidelity relative to the actual index — which is typically very tight but can diverge during market dislocations.

Capital deployment

CPRA held approximately $22–23 million in net assets as of June 2026, a small fund reflective of its niche positioning. The 0.69% management fee is charged annually regardless of market conditions or outcome period length. For an investor buying late in a cycle (e.g., in February), the fee applies for only two months of benefits, making the economic case less attractive.

Calamos’ motivation for launching a Russell 2000 variant was straightforward: the small-cap segment has its own investor base, distinct from Nasdaq-100 traders, and the higher volatility allows for more attractive structured deals. The fund issuer is the Calamos ETF Trust, the same domicile used for CPNQ and CPNS.

The segment view: what’s in the Russell 2000

The Russell 2000 spans nearly every U.S. business segment: financial services (regional banks, credit-focused nonbanks), healthcare (small-cap hospitals, device makers, biotech), industrials (machinery, distribution, transportation), consumer (restaurants, retailers), technology (software, semiconductors), and energy (smaller E&P firms). Unlike an index of large-cap technology companies, which has a clear sector tilt, the Russell 2000 is genuinely diversified — no single segment typically accounts for more than 15–20% of the index. This diversification cuts both ways: it provides natural hedging, but it also means there is no dominant narrative driving the index.

CPRA captures this full spectrum with a cap and floor applied to the index as a whole. An investor betting that small caps will outperform should ask whether the cap is wide enough to make the bet worthwhile; an investor using it for downside protection should confirm that the floor is attractive relative to the current market price of put options bought independently.

How to evaluate CPRA

Start with the Calamos fact sheet and prospectus, which detail the current outcome period’s cap and floor. Check when you intend to buy and sell — buying late in a cycle, even if the cap is attractive, locks you into a short benefit window. Compare the cap to historical Russell 2000 annual returns (typically 9–15% in bull years) to gauge whether you are capping at a level that preserves meaningful upside. And evaluate the fee: 0.69% charged on a small-cap position with high annual volatility is a noticeable drag relative to passive Russell 2000 index funds (which cost 0.10% or less).

CPRA is not a recommendation but a tactical structure: useful for investors who want Russell 2000 exposure, expect volatility, and prefer insurance to downside risk over a defined outcome period.